Your browser doesn't support javascript.
loading
Ovarian tumors of low malignant potential.
Trimble, E L; Trimble, C L.
Affiliation
  • Trimble EL; National Cancer Institute, 6130 Executive Boulevard, Suite 741, MSC 7436, Bethesda, MD 20892-7436, USA.
Curr Treat Options Oncol ; 2(2): 103-8, 2001 Apr.
Article in En | MEDLINE | ID: mdl-12057128
Ovarian tumors of low malignant potential (LMP) differ from epithelial ovarian carcinoma in etiology, molecular biology, and prognosis. LMP tumors are not precursor lesions to ovarian carcinoma. Treatment is primarily surgical. Women found to have an ovarian tumor of LMP should undergo removal of the involved adnexa; surgical staging; and cytoreductive surgery. Women in the reproductive years should be given the option of conservative surgery, preserving the contralateral adnexa and uterus. There is no proven benefit to adjuvant chemotherapy or radiotherapy after primary surgery. In most cases, the diagnosis of an ovarian tumor of LMP conveys good prognosis, with excellent long-term survival.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Cysts Type of study: Guideline / Prognostic_studies Limits: Female / Humans Language: En Journal: Curr Treat Options Oncol Journal subject: NEOPLASIAS Year: 2001 Document type: Article Affiliation country: United States Country of publication: United States
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Cysts Type of study: Guideline / Prognostic_studies Limits: Female / Humans Language: En Journal: Curr Treat Options Oncol Journal subject: NEOPLASIAS Year: 2001 Document type: Article Affiliation country: United States Country of publication: United States